Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orgamol was a Swiss-based contract manufacturing organization (CMO) specializing in the production of active pharmaceutical ingredients (APIs) and advanced intermediates for the global pharmaceutical industry. Founded in 1954 and headquartered in Evionnaz, Switzerland, the company built a reputation for expertise in custom synthesis and complex multi-step chemical processes. In 2005, Orgamol was acquired by the German chemical company BASF to significantly expand its fine chemicals and life science portfolio. Following the acquisition, Orgamol's facilities and technical capabilities were integrated into the BASF Pharma Solutions business unit. The company's legacy remains centered on its high-quality manufacturing standards and its role in supporting the supply chains of major pharmaceutical firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orgamol Pharma Solutions.